Endoscopic therapy for early esophageal cancer and premalignant lesions in barrett's esophagus

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

The major medical consequence of Barrett's esophagus (BE) is the potential risk of development of esophageal adenocarcinoma. It is the management of this cancer risk and early cancers that is the focus of endoscopic therapies. As the risk of cancer increases, the types of endoscopic therapies that can be applied become more invasive. These therapies involve removal of the esophageal mucosa and portions of the submucosa, thermal therapies to cauterize the neoplastic tissue, and the use of photochemical therapies that cause localized tissue necrosis. Case series suggest that these treatments are effective and in selected patients can be used in lieu of surgery or in patients who are not surgical candidates. However, randomized controlled trials are lacking.

Original languageEnglish (US)
Title of host publicationEndoscopic Oncology: Gastrointestinal Endoscopy and Cancer Management
PublisherHumana Press
Pages43-51
Number of pages9
ISBN (Print)158829532X, 9781588295323
DOIs
StatePublished - 2006

Fingerprint

Barrett Esophagus
Esophageal Neoplasms
Therapeutics
Neoplasms
Risk Management
Adenocarcinoma
Necrosis
Randomized Controlled Trials
Hot Temperature

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Iyer, P. G., & Wang, K. K. N. (2006). Endoscopic therapy for early esophageal cancer and premalignant lesions in barrett's esophagus. In Endoscopic Oncology: Gastrointestinal Endoscopy and Cancer Management (pp. 43-51). Humana Press. https://doi.org/10.1007/978-1-59745-172-7_5

Endoscopic therapy for early esophageal cancer and premalignant lesions in barrett's esophagus. / Iyer, Prasad G; Wang, Kenneth Ke Ning.

Endoscopic Oncology: Gastrointestinal Endoscopy and Cancer Management. Humana Press, 2006. p. 43-51.

Research output: Chapter in Book/Report/Conference proceedingChapter

Iyer, PG & Wang, KKN 2006, Endoscopic therapy for early esophageal cancer and premalignant lesions in barrett's esophagus. in Endoscopic Oncology: Gastrointestinal Endoscopy and Cancer Management. Humana Press, pp. 43-51. https://doi.org/10.1007/978-1-59745-172-7_5
Iyer PG, Wang KKN. Endoscopic therapy for early esophageal cancer and premalignant lesions in barrett's esophagus. In Endoscopic Oncology: Gastrointestinal Endoscopy and Cancer Management. Humana Press. 2006. p. 43-51 https://doi.org/10.1007/978-1-59745-172-7_5
Iyer, Prasad G ; Wang, Kenneth Ke Ning. / Endoscopic therapy for early esophageal cancer and premalignant lesions in barrett's esophagus. Endoscopic Oncology: Gastrointestinal Endoscopy and Cancer Management. Humana Press, 2006. pp. 43-51
@inbook{c83ec19e16cc4a5895503247ba06e9ca,
title = "Endoscopic therapy for early esophageal cancer and premalignant lesions in barrett's esophagus",
abstract = "The major medical consequence of Barrett's esophagus (BE) is the potential risk of development of esophageal adenocarcinoma. It is the management of this cancer risk and early cancers that is the focus of endoscopic therapies. As the risk of cancer increases, the types of endoscopic therapies that can be applied become more invasive. These therapies involve removal of the esophageal mucosa and portions of the submucosa, thermal therapies to cauterize the neoplastic tissue, and the use of photochemical therapies that cause localized tissue necrosis. Case series suggest that these treatments are effective and in selected patients can be used in lieu of surgery or in patients who are not surgical candidates. However, randomized controlled trials are lacking.",
author = "Iyer, {Prasad G} and Wang, {Kenneth Ke Ning}",
year = "2006",
doi = "10.1007/978-1-59745-172-7_5",
language = "English (US)",
isbn = "158829532X",
pages = "43--51",
booktitle = "Endoscopic Oncology: Gastrointestinal Endoscopy and Cancer Management",
publisher = "Humana Press",

}

TY - CHAP

T1 - Endoscopic therapy for early esophageal cancer and premalignant lesions in barrett's esophagus

AU - Iyer, Prasad G

AU - Wang, Kenneth Ke Ning

PY - 2006

Y1 - 2006

N2 - The major medical consequence of Barrett's esophagus (BE) is the potential risk of development of esophageal adenocarcinoma. It is the management of this cancer risk and early cancers that is the focus of endoscopic therapies. As the risk of cancer increases, the types of endoscopic therapies that can be applied become more invasive. These therapies involve removal of the esophageal mucosa and portions of the submucosa, thermal therapies to cauterize the neoplastic tissue, and the use of photochemical therapies that cause localized tissue necrosis. Case series suggest that these treatments are effective and in selected patients can be used in lieu of surgery or in patients who are not surgical candidates. However, randomized controlled trials are lacking.

AB - The major medical consequence of Barrett's esophagus (BE) is the potential risk of development of esophageal adenocarcinoma. It is the management of this cancer risk and early cancers that is the focus of endoscopic therapies. As the risk of cancer increases, the types of endoscopic therapies that can be applied become more invasive. These therapies involve removal of the esophageal mucosa and portions of the submucosa, thermal therapies to cauterize the neoplastic tissue, and the use of photochemical therapies that cause localized tissue necrosis. Case series suggest that these treatments are effective and in selected patients can be used in lieu of surgery or in patients who are not surgical candidates. However, randomized controlled trials are lacking.

UR - http://www.scopus.com/inward/record.url?scp=84891434633&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84891434633&partnerID=8YFLogxK

U2 - 10.1007/978-1-59745-172-7_5

DO - 10.1007/978-1-59745-172-7_5

M3 - Chapter

SN - 158829532X

SN - 9781588295323

SP - 43

EP - 51

BT - Endoscopic Oncology: Gastrointestinal Endoscopy and Cancer Management

PB - Humana Press

ER -